NCT04403594

Brief Summary

Investigators will use muscular dry needling in the calf of one lower extremity, followed by treadmill training with functional electrical stimulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 19, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 13, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 27, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 18, 2021

Completed
Last Updated

September 29, 2021

Status Verified

September 1, 2021

Enrollment Period

1.6 years

First QC Date

May 13, 2020

Last Update Submit

September 27, 2021

Conditions

Outcome Measures

Primary Outcomes (6)

  • 6 minute walk test

    distance walked over 6 minutes assessed at the start of the study and after 6 weeks.

    up to 7 weeks

  • 25-foot walk

    time to walk 25 feet assessed at the start of the study and after 6 weeks.

    up to 7 weeks

  • Berg Balance Scale

    Balance test conducted at the start of the study and after 6 weeks.

    up to 7 weeks

  • Modified Fatigue Impact Scale

    patient-reported questionnaire collected at the start of the study and after 6 weeks.

    up to 7 weeks

  • Toe taps on force plate

    number of toe taps in 10 seconds counted at the start of the study and after 6 weeks.

    up to 7 weeks

  • EMG data of both lower extremities

    Electromyography (EMG) will be conducted at the start of the study and after 6 weeks. EMG is an electrodiagnostic technique for evaluating and recording the electrical activity produced by skeletal muscles. This is completed using electrodes that are placed on the skin, which detects the electric potential generated by muscle cells when these cells are electrically or neurologically activated. These action potentials are measured and recorded on a computer.

    up to 7 weeks

Study Arms (1)

MS with spasticity of one lower extremity

A person diagnosed with Multiple Sclerosis and spasticty of one lower extremity. The person must be able to walk 25 feet and cannot have had Botox in the lower extremity on the last 6 months.

Other: dry needling

Interventions

dry needling followed by functional electrical stimulation and treadmill training

Also known as: functional electrical stimulation
MS with spasticity of one lower extremity

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

People with a diagnosis of MS and spasticity

You may qualify if:

  • Diagnosis of MS based on MRI
  • Ability walk 25 feet
  • Spasticity of one lower extremity

You may not qualify if:

  • Blood clot within the last 6 months
  • Bleeding disorder
  • Active cancer
  • Botox in the lower extremities within 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oklahoma Medical Research Foundation

Oklahoma City, Oklahoma, 73104, United States

Location

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Officials

  • Shirley James, PhD

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2020

First Posted

May 27, 2020

Study Start

August 19, 2019

Primary Completion

April 1, 2021

Study Completion

April 18, 2021

Last Updated

September 29, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations